PAUL THOMAS
CIK 1166776 · President and CEO · last filed 2026-06-11
PAUL THOMAS is a President and CEO who has filed 72 SEC Form 4 insider transactions across 11 companies since 2007. The most recent filing, for TELA, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$15.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $602.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$602.0K
11
72
-$15.32M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TELA | Director | 23,600 | $0.86 | $20.3K | $0 | 1 | 2026-06-11 |
| AXGN | Director | 13,528 | $43.00 | $581.7K | -$633.7K | 10 | 2025-12-10 |
| ABIOMED INC (ABMD) Delisted | Director | 6,357 | $381.02 | $2.42M | -$3.42M | 13 | 2022-11-03 |
| SURGALIGN HOLDINGS, INC. (SRGA) Delisted | Director | 28,610 | $0.18 | $5.2K | $0 | 3 | 2022-08-17 |
| RTI SURGICAL, INC. (RTIX) Delisted | Director | 0 | — | — | $0 | 5 | 2019-03-11 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Director | 0 | — | — | $0 | 6 | 2016-11-30 |
| Roka BioScience, Inc. (ROKA) Delisted | President and CEO | 85,494 | — | — | $0 | 4 | 2016-11-10 |
| ABIOMED INC (APOL) Delisted | Director | 22,932 | — | — | -$2.60M | 11 | 2016-08-11 |
| KINETIC CONCEPTS INC (KCI) Delisted | President, LifeCell Corp. | 0 | — | — | $0 | 1 | 2008-08-27 |
| LIFECELL CORP (VITA) Delisted | Chairman, President and CEO | 0 | — | — | -$8.66M | 10 | 2008-06-04 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 38,931 | — | — | $0 | 1 | 2007-03-05 |
Recent Filings
72 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | TELA | Grant (A) | +23,600 | $0 | EDGAR |
| 2025-12-10 | AXGN | Sell (S) | −21,399 | -$633.7K | EDGAR |
| 2025-06-20 | AXGN | Grant (A) | — | $0 | EDGAR |
| 2024-09-17 | AXGN | Grant (A) | +2,875 | $0 | EDGAR |
| 2024-09-04 | AXGN | Exer (M) | +11,904 | $0 | EDGAR |
| 2024-06-10 | AXGN | Grant (A) | +10,653 | $0 | EDGAR |
| 2023-09-07 | AXGN | Grant (A) | — | $0 | EDGAR |
| 2023-06-05 | AXGN | Exer (M) | +6,459 | $0 | EDGAR |
| 2022-12-27 | — | Disp (D) | −6,357 | $0 | |
| 2022-11-03 | ABIOMED INC (ABMD) Delisted | Sell (S) | −1,000 | -$379.4K | EDGAR |